Dolph Lundgren Considered Assisted Suicide After Misdiagnosis
The actor revealed in his memoir that a cancer misdiagnosis led him to contemplate end-of-life options.
Updated on Sept. 23, 2026 in Cancer
After being diagnosed with kidney cancer in 2015 and experiencing a recurrence in 2020, actor Dolph Lundgren contemplated assisted suicide due to his deteriorating condition. His outlook shifted after Dr. Alexandra Drakaki at UCLA Health correctly identified that he was suffering from lung cancer rather than kidney cancer.
Why it matters
This case highlights the life-saving impact of accurate diagnostic testing, as the medications for his assumed condition were ineffective. It also illustrates the profound psychological toll and desperation patients may experience when faced with an apparent terminal prognosis.
Dr. Alexandra Drakaki identified a specific cellular mutation common to lung cancer, which allowed for a change in treatment. This occurred after the patient had already undergone ineffective treatments for kidney cancer.
The players
Dolph Lundgren
He is an actor who has starred in numerous action films and recently published a memoir.
Dr. Alexandra Drakaki
She is a medical professional at UCLA Health who successfully identified Lundgren's actual cancer type.
The details
Following the discovery that his tumors were actually related to lung cancer, Lundgren received targeted medications that led to his remission. He eventually announced he was cancer-free in 2024 and shared his journey in his 2026 memoir.
Timeline
Lundgren was first diagnosed with kidney cancer in 2015.
More tumors were found in Lundgren in 2020.
Lundgren announced he was cancer-free in 2024.
Lundgren published his memoir on September 22, 2026.
Health Landscape
The actor's journey highlights the critical importance of specialized genomic testing in oncology to distinguish between similar-appearing conditions. His eventual recovery marks a departure from the grim outcomes associated with misidentified metastatic cancers.
This story underscores the value of seeking second opinions and specialized consultations at major research hospitals when facing a serious diagnosis. Patients may find hope in the fact that advanced mutation-based diagnostic testing can reveal treatable alternatives to perceived terminal cases.
The takeaway
Patients navigating serious diagnoses should always advocate for comprehensive genomic testing to ensure the accuracy of their medical care. Seeking clarity from specialized medical centers can prevent unnecessary suffering and potentially uncover more effective treatment pathways.
Further reading
For more information on diagnostic accuracy and treatment advancements, visit Cancer.
Source note: This article includes information reported by TV Insider.
